老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
KraneShares MSCI All China Health Care Index ETF
18.36
+0.0793
0.43%
盤後：
18.30
-0.0588
-0.32%
19:30 EDT
成交量：
3.00萬
成交額：
54.97萬
市值：
1.08億
市盈率：
- -
高：
18.43
開：
18.31
低：
18.20
收：
18.28
52周最高：
21.50
52周最低：
14.38
股本：
590.02萬
流通股本：
590.02萬
量比：
1.09
換手率：
0.51%
股息：
0.71
股息率：
3.89%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
信達生物(01801.HK)：腫瘤與綜合產品線雙輪驅動 業績保持強勁增長
中金财经
·
4小時前
中國創新藥正深度融入全球產業版圖
智通财经
·
昨天
藥明生物(02269.HK)註銷3982.45萬股已回購股份
智通财经
·
09/18
百濟神州(06160)出現大手買入2.54萬股，成交價$213.6，涉資542.544萬
阿斯达克财经
·
09/18
CXO板塊上揚 昭衍新藥（06127）漲5.64%、金斯瑞生物科技（01548）漲4.78%
金吾财讯
·
09/18
生物醫藥概念走強 再鼎醫藥（09688）升逾4% 十部門出台醫藥工業十五五規劃
金吾财讯
·
09/18
康方生物迎大敵：榮昌生物RC148亮相世界肺癌大會 預計峯值銷售額約36億元
新浪证券
·
09/17
研報掘金丨中金：上調康方生物目標價至130港元，維持「跑贏行業」評級
格隆汇
·
09/17
港股指數早盤集體承壓 恒指半日跌0.73% 老鋪黃金（06181）跌超3%
金吾财讯
·
09/17
開啓中國創新藥智能體時代，Veeva發布研發與質量領域AI產品與路線圖
美通社
·
09/16
石藥集團(01093)：SYH2069注射液用於治療成人2型糖尿病的II期臨床試驗在中國首個研究中心正式啓動
智通财经网
·
09/16
信達生物(01801)出現大手買入5.45萬股，成交價$94.5，涉資515.025萬
阿斯达克财经
·
09/16
創新藥概念局部走強 恒瑞醫藥（01276）漲2.74% 機構料企業扭虧節點到來
金吾财讯
·
09/16
康方生物(09926)出現大手賣出8.1萬股，成交價$90.0，涉資729萬
阿斯达克财经
·
09/16
康方生物(09926)股價下跌5.039%，現價港幣$90.45
阿斯达克财经
·
09/16
百濟神州(06160)出現大手賣出5.12萬股，成交價$214.8，涉資1.1千萬
阿斯达克财经
·
09/16
藥明生物(02269)出現大手賣出18.3萬股，成交價$49.9，涉資913.17萬
阿斯达克财经
·
09/16
石藥集團(01093)：SYS 6010於中國獲國家藥監局納入突破性治療品種名單用於治療驅動基因陰性非鱗狀非小細胞肺癌患者
智通财经
·
09/15
可以多活8.2個月！國產雙抗挑戰全球腫瘤「藥王」總生存期勝出
第一财经
·
09/15
智通港股早知道 | 國產創新藥WCLC數據密集兑現 投行看好中國CRO/CDMO復甦明確
智通财经
·
09/15
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/KURE/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.3593,"timestamp":1789761600000,"preClose":18.28,"halted":0,"volume":30007,"hourTrading":{"tag":"盘后","latestPrice":18.3005,"preClose":18.3593,"latestTime":"19:30 EDT","volume":9,"amount":164.8058,"timestamp":1789774205135,"change":-0.0588,"changeRate":-0.003203,"amplitude":0},"delay":0,"changeRate":0.004338074398249449,"floatShares":5900168,"shares":5900168,"eps":0,"marketStatus":"休市中","change":0.0793,"latestTime":"09-18 16:00:00 EDT","open":18.31,"high":18.4299,"low":18.2,"amount":549746.6642979999,"amplitude":0.012577,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.28,"sharesOutstanding":4750002,"nav":18.2,"aum":106490719.49,"dividendRate":0.038934,"bidAskSpread":0.011872,"postHourTrading":{"tag":"盘后","latestPrice":18.3005,"preClose":18.3593,"latestTime":"19:30 EDT","volume":9,"amount":164.8058,"timestamp":1789774205135,"change":-0.0588,"changeRate":-0.003203,"amplitude":0},"volumeRatio":1.0912112465055275,"impliedVol":0.1722,"impliedVolPercentile":0.3665},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5900168,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0912112465055275,"shares":5900168,"dividePrice":0.7148,"high":18.4299,"amplitude":0.012577,"preClose":18.28,"low":18.2,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":18.3593,"eps":0,"divideRate":0.038934,"volume":30007,"delay":0,"ttmEps":0,"open":18.31,"prevYearClose":17.04,"prevWeekClose":17.74,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":17.74,"twentyDayClose":19.34,"sixtyDayClose":15.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668064159","title":"信達生物(01801.HK)：腫瘤與綜合產品線雙輪驅動 業績保持強勁增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2668064159","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668064159?lang=zh_tw&edition=fundamental","pubTime":"2026-09-20 01:17","pubTimestamp":1789838222,"startTime":"0","endTime":"0","summary":" 近日，公司发布2026 年中期业绩，2026H1 实现总收入86.18 亿元，同比增长44.8%，其中产品收入82.01 亿元，同比增长56.7%；实现IFRS 净利润12.53 亿元，同比增长50.2%。 2026H1 公司实现总收入86.18 亿元，同比增长44.8%，其中产品收入82.01亿元，同比增长56.7%，肿瘤与综合产品线共同驱动收入增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260920/32375333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU0607220059.USD","BK1583","LU0149534421.HKD","KURE","LU2097828631.EUR","LU0326950275.SGD","LU0455707207.USD","LU2097828805.USD","LU0502904849.HKD","LU2097828474.EUR","LU2328871848.SGD","LU2097828557.USD","HK0000165453.HKD","01801","LU1969619763.USD","LU0463099449.HKD","LU1831875114.USD","LU2488822045.USD","BK1161","LU1188198961.HKD","LU2097828714.EUR","LU2242644610.SGD","LU0244354667.USD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668397677","title":"中國創新藥正深度融入全球產業版圖","url":"https://stock-news.laohu8.com/highlight/detail?id=2668397677","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668397677?lang=zh_tw&edition=fundamental","pubTime":"2026-09-19 07:30","pubTimestamp":1789774200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668926770","title":"藥明生物(02269.HK)註銷3982.45萬股已回購股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2668926770","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668926770?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 21:19","pubTimestamp":1789737584,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0052750758.USD","LU0979878070.USD","LU0516422366.SGD","LU0307460666.USD","02269","LU0819121731.USD","LU0561508036.HKD","LU0128526141.USD","LU0572944931.SGD","LU1242518857.USD","LU0348735423.USD","LU0320764599.SGD","BK1610","LU0359201612.USD","SG9999002562.SGD","LU0634319403.HKD","LU0456846285.SGD","LU0540923850.HKD","LU1720050803.USD","LU0708995583.HKD","LU0029874061.USD","KURE","LU0417516738.SGD","LU0708995153.HKD","LU1794554557.SGD","BK1521","LU0516423091.SGD","LU0348827113.USD","LU0516423174.USD","LU0320764243.SGD","LU0181495838.USD","LU0348825331.USD","BK1589","LU1688375341.USD","LU0856984785.SGD","BK1576","LU2039709279.SGD","LU0516422952.EUR","LU0516422440.USD","LU0043850808.USD","IE00B0JY6N72.USD","LU0359202008.SGD","SG9999002463.SGD","LU0140636845.USD","LU0823426308.USD","LU0456827905.SGD","LU1242518931.SGD","LU0039217434.USD","LU0823426480.USD","LU0417516902.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668174669","title":"百濟神州(06160)出現大手買入2.54萬股，成交價$213.6，涉資542.544萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2668174669","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668174669?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 13:10","pubTimestamp":1789708200,"startTime":"0","endTime":"0","summary":"[大手成交]百济神州(06160)在下午01:10出现大手买入，成交量为2.54万，成交价为港币$213.6，涉资542.544万。至目前为止，股价升1.232%，今日最高价为$216.0，而最低价为$212.0，总成交量为119.6万股，总成交金额港币$2.556亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609184080/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609184080/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0239","LU0307460666.USD","KURE","LU1303224171.USD","BK1583","LU1969619763.USD","688235","LU1770034418.SGD","BK1161","06160","LU1719994722.HKD","LU2328871848.SGD","BK1500","BK1588","LU1251922891.USD","LU0588546209.SGD","LU0228659784.USD","LU0828237510.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668919819","title":"CXO板塊上揚 昭衍新藥（06127）漲5.64%、金斯瑞生物科技（01548）漲4.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668919819","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668919819?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 09:46","pubTimestamp":1789695974,"startTime":"0","endTime":"0","summary":"金吾财讯 | CXO板块上扬，昭衍新药 涨5.64%，金斯瑞生物科技涨4.78%，维亚生物涨2.15%，泰格医药涨1.93%，药明生物涨1.80%，凯莱英涨1.79%，药明康德涨1.01%，百济神州涨0.95%。中信建投近日研报指，CXO是创新药产业链专业化分工的重要载体，也是连接药物研发与商业化生产的关键基础设施。随着内外需改善逐步传导至订单与业绩，CXO有望进入新一轮增长阶段。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991930","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348827113.USD","LU0029874905.USD","LU0561508036.HKD","LU2242644610.SGD","LU1251922891.USD","LU2039709279.SGD","WX","BK1588","LU0516423174.USD","06160","01873","LU1242518857.USD","LU1719994722.HKD","LU0228659784.USD","LU0320764243.SGD","LU0348825331.USD","SG9999002562.SGD","02359","IE00B0JY6N72.USD","LU0029874061.USD","06127","LU0181495838.USD","BK1610","LU0469268626.HKD","CXO","LU0634319403.HKD","LU0052750758.USD","06821","LU0856984785.SGD","LU0828237510.HKD","603127","LU0320764599.SGD","LU0359202008.SGD","LU0128522744.USD","BK1521","03347","KURE","LU0039217434.USD","LU0348735423.USD","LU1880383366.USD","02269","LU0051755006.USD","BK0216","LU0588546209.SGD","LU1688375341.USD","01548","LU3063872942.SGD","LU0456846285.SGD","LU1242518931.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668813919","title":"生物醫藥概念走強 再鼎醫藥（09688）升逾4% 十部門出台醫藥工業十五五規劃","url":"https://stock-news.laohu8.com/highlight/detail?id=2668813919","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668813919?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 09:45","pubTimestamp":1789695942,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股生物医药概念走强，截至发稿，金斯瑞生物科技 涨4.78%，再鼎医药涨4.57%，君实生物涨3.32%，泰格医药涨1.93%，药明生物涨1.70%。消息面上，工业和信息化部、国家发展改革委等十部门联合发布《医药工业发展“十五五”规划》。《规划》提出到2030年的发展目标：生物医药研发应用稳居世界前列，创新驱动效能充分释放，重点领域关键核心技术实现系统性突破，生物医药产业加速成为国家新兴支柱产业。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991931","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","LU0128522744.USD","LU0348825331.USD","01548","HK0000306685.HKD","LU0979878070.USD","BK4588","09688","SG9999002463.SGD","LU2488822045.USD","03347","BK1141","LU0140636845.USD","LU1242518931.SGD","LU0456846285.SGD","LU0572944931.SGD","LU0561508036.HKD","LU0856984785.SGD","LU0516423091.SGD","LU0043850808.USD","LU0128526141.USD","BK1610","LU3063872942.SGD","LU0320764243.SGD","BK1521","BK1583","KURE","399441","LU0634319403.HKD","BK4531","161726","LU0417516902.SGD","LU0516422366.SGD","LU0348827113.USD","ZLAB","LU0348735423.USD","LU0588546209.SGD","LU0516423174.USD","LU0320764599.SGD","01877","BK1161","XBI","HK0000320264.USD","LU1688375341.USD","02269","LU0181495838.USD","LU0417516738.SGD","BK4139","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668959205","title":"康方生物迎大敵：榮昌生物RC148亮相世界肺癌大會 預計峯值銷售額約36億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2668959205","media":"新浪证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668959205?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 14:17","pubTimestamp":1789625820,"startTime":"0","endTime":"0","summary":"9月15日，荣昌生物与艾伯维联合开发的PD-1/VEGF双抗RC148一线治疗鳞状和非鳞状非小细胞肺癌的II期临床数据以口头报告形式在世界肺癌大会亮相。基于以上参数计算，RC148 大中华区峰值年销售额约为 36 亿元。从时间维度来看，RC148 预计 2030 年左右获批上市，通常创新药上市后需经历 5-7 年的市场爬坡期达到销售峰值，预计 2036 年左右达到峰值销售额，距离当前时点约 10 年。结合 0.50 的临床成功概率，最终 RC148 大中华区管线的风险调整净现值约为 5.6 亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-09-17/doc-iniscksf0292708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK0239","09995","LU1064130708.USD","KURE","BK1583","IE00B5MMRT66.SGD","LU2399975544.HKD","LU2476274720.SGD","LU1720050803.USD","09926","LU1064131003.USD","IE00B543WZ88.USD","LU0348825331.USD","LU0348784397.USD","LU0561508036.HKD","LU2778985437.USD","LU1961090484.USD","LU0348783233.USD","LU2476274308.USD","IE00BPRC5H50.USD","BK1161","LU0348827113.USD","LU0348766576.USD","688331","LU2148510915.USD","LU0417516902.SGD","LU2328871848.SGD","LU0417516738.SGD","LU1969619763.USD","LU0634319403.HKD","LU0540923850.HKD","LU2488822045.USD","LU1794554557.SGD","LU0348767384.USD","LU0417516571.SGD","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668956446","title":"研報掘金丨中金：上調康方生物目標價至130港元，維持「跑贏行業」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2668956446","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668956446?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 13:36","pubTimestamp":1789623377,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0348783233.USD","LU1961090484.USD","IE00BPRC5H50.USD","LU2476274308.USD","LU0417516738.SGD","IE00B543WZ88.USD","LU1720050803.USD","LU0540923850.HKD","LU0417516902.SGD","LU0561508036.HKD","IE00B5MMRT66.SGD","KURE","LU0348827113.USD","LU0348784397.USD","BK1161","LU2778985437.USD","LU2399975544.HKD","09926","LU2476274720.SGD","LU0417516571.SGD","LU0348767384.USD","LU1794554557.SGD","LU0348735423.USD","LU0348766576.USD","LU0348825331.USD","BK1574","LU0634319403.HKD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668095535","title":"港股指數早盤集體承壓 恒指半日跌0.73% 老鋪黃金（06181）跌超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668095535","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668095535?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 12:13","pubTimestamp":1789618423,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股指数早盘集体承压，截至午间收盘，恒生指数下跌0.73%；国企指数下跌0.58%，恒生科技指数下跌0.76%。板块方面，半导体设备概念局部走强，截至午间收盘，天数智芯涨6.97%，云英谷科技涨4.61%，圣邦股份涨2%，壁仞科技涨3.04%。中信证券发文研究称，2026年8月中国社零总额39,824亿元/同比+0.4%，限额以上商品零售总额13,504亿元/同比-4.0%，剔除汽车、石油类限额以上零售额同比+3.9%。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/ZDMzODA5NjAwODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDMzODA5NjAwODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991873","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","07500","BK1583","LU0307460666.USD","LU2097828474.EUR","KCAI","LU1808992512.USD","02359","LU1969619763.USD","LU0320764599.SGD","LU2097828805.USD","06181","MHImain","LU0128522157.USD","LU0149721374.USD","03419","03115","KURE","LU1303224171.USD","LU0228659784.USD","HHImain","LU2125910500.SGD","02833","83115","03692","LU1244550577.SGD","LU2097828557.USD","HSImain","BK4588","513600","07200","LU0029875118.USD","LU0543330483.HKD","LU1251922891.USD","03037","LU2045819591.USD","HSI","82800","07300","LU0164880469.USD","LU0214875030.USD","06160","VXUS","09115","LU1244550221.USD","LU0828237510.HKD","02338","01801","MCHmain","02800"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668337529","title":"開啓中國創新藥智能體時代，Veeva發布研發與質量領域AI產品與路線圖","url":"https://stock-news.laohu8.com/highlight/detail?id=2668337529","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668337529?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 22:18","pubTimestamp":1789568280,"startTime":"0","endTime":"0","summary":"筑造简化与标准化AI基础设施，以平台级原生合规AI智驱药企效能跃迁 上海2026年9月16日 /美通社/ --在日前举行的2026 Veeva中国研发及质量峰会上，全球生命科学行业云解决方案与AI应用创新者 Veeva Systems发布了最新的研发与质量领域AI战略和产品路线图，加速药物研发、生产与上市，更快惠及患者。\" 作为深耕生命科学行业的云解决方案与AI应用创新者，Veeva在药物研发与质量领域积累了深厚的技术、运营经验和卓越的人才团队。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5049344_ZH49344_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5049344_ZH49344_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4504","LGHT","LU0006306889.USD","LU1989764664.SGD","LU0058720904.USD","KURE","LU0289739699.SGD","LU1989764748.USD","QTOC","BK4585","AGIX","BK4167","BK4534","BK4528","LU0106261372.USD","EKG","BK4588","VTHR","AIPO","BK4613","CHAT","VEEV","LU0266013472.USD","LU0170899867.USD","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667020436","title":"石藥集團(01093)：SYH2069注射液用於治療成人2型糖尿病的II期臨床試驗在中國首個研究中心正式啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=2667020436","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667020436?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 18:39","pubTimestamp":1789555160,"startTime":"0","endTime":"0","summary":"石药集团(01093)发布公告，集团开发的SYH2069注射液(“该产品”)用于治疗成人2型糖尿病的II期临床试验(SYH2069-003)已在中国首个研究中心正式启动。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggaonew/ganggugongg6.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggaonew/ganggugongg6.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496940.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0067412154.USD","IE00B031HY20.USD","LU1008478684.HKD","LU1226288170.HKD","BK1191","LU2039709279.SGD","IE0008369823.USD","IBBQ","BK1521","SG9999004220.SGD","LU1328277881.USD","LU1960683339.HKD","KURE","LU1152091168.USD","LU1951186391.HKD","IE00B5MMRT66.SGD","HK0000165453.HKD","PSYK","IE0008368742.USD","LU0501845795.SGD","LU1993786604.SGD","LU1226288253.USD","01093","LU1807302812.USD","BMED","IE00B543WZ88.USD","LU0326950275.SGD","IE00BZ08YS42.EUR","LU0315179316.USD","LU1152091754.HKD","LU0072913022.USD","LU1226287875.USD","LU1226287529.USD","IE00BZ08YT58.USD","BK1515","IBBJ","LU1813983027.USD","IE00BZ08YR35.GBP","LU0880133367.SGD","MDTX","LU0140636845.USD","LU1226287792.SGD","LU0314109678.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671833","title":"信達生物(01801)出現大手買入5.45萬股，成交價$94.5，涉資515.025萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671833","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671833?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:43","pubTimestamp":1789526580,"startTime":"0","endTime":"0","summary":"[大手成交]信达生物(01801)在上午10:43出现大手买入，成交量为5.45万，成交价为港币$94.5，涉资515.025万。至目前为止，股价跌0.632%，今日最高价为$95.45，而最低价为$93.85，总成交量为225.069万股，总成交金额港币$2.126亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609163715/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609163715/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1969619763.USD","LU2097828714.EUR","LU2097828805.USD","BK1589","01801","LU0326950275.SGD","KURE","LU0455707207.USD","BK1583","LU0244354667.USD","LU1188198961.HKD","LU0607220059.USD","LU2488822045.USD","LU1831875114.USD","LU2242644610.SGD","BK1161","LU2097828557.USD","LU2097828474.EUR","LU0502904849.HKD","LU2328871848.SGD","LU0463099449.HKD","LU0149534421.HKD","LU2097828631.EUR","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667617679","title":"創新藥概念局部走強 恒瑞醫藥（01276）漲2.74% 機構料企業扭虧節點到來","url":"https://stock-news.laohu8.com/highlight/detail?id=2667617679","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667617679?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:20","pubTimestamp":1789525259,"startTime":"0","endTime":"0","summary":"消息面上，国金证券表示，创新药企业扭亏节点到来，全年临床数据催化密集，叠加已BD出海管线海外临床进展顺利，看好创新药板块投资机会。诚通证券表示，2025年为创新药海外授权BD大年，2026H1我国创新药海外授权BD交易继续大幅增长，总交易金额已接近1000亿美元，国产创新药已从偶发性出海转变为系统性趋势。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991724","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276","LU1997244956.HKD","LU1023057109.AUD","LU0307460666.USD","LU0405327148.USD","LU2097828557.USD","LU2039709279.SGD","IE00BZ08YS42.EUR","LU0140636845.USD","LU0588546209.SGD","159992","LNGR","09688","BK1515","LU0128526141.USD","MEDX","LU0043850808.USD","LU0359201612.USD","LU0516422952.EUR","LU2097828805.USD","BK1574","06978","LU1655091616.SGD","IE00B0JY6N72.USD","LU0561508036.HKD","BK0183","600276","LU0456846285.SGD","LU0516423174.USD","LU2580892789.USD","LU2488822045.USD","LU1580142542.USD","BK0239","02637","LU0327786744.USD","01177","BK0060","IBBQ","LU0348827113.USD","LU1255011170.USD","01477","LU1820825898.SGD","LU2148510915.USD","LU1328615791.USD","02269","LU1146622755.USD","LU0348825331.USD","BK0188","LU0417516902.SGD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667167913","title":"康方生物(09926)出現大手賣出8.1萬股，成交價$90.0，涉資729萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2667167913","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667167913?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:20","pubTimestamp":1789525200,"startTime":"0","endTime":"0","summary":"[大手成交]康方生物(09926)在上午10:20出现大手卖出，成交量为8.1万，成交价为港币$90.0，涉资729万。至目前为止，股价跌5.354%，今日最高价为$94.6，而最低价为$89.95，总成交量为534.6万股，总成交金额港币$4.89亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609163518/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609163518/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0540923850.HKD","LU0417516738.SGD","LU2476274308.USD","LU0348827113.USD","LU0417516571.SGD","BK1161","IE00BPRC5H50.USD","LU1794554557.SGD","IE00B543WZ88.USD","LU0348766576.USD","LU0348825331.USD","LU0417516902.SGD","LU1961090484.USD","LU0634319403.HKD","09926","LU0348767384.USD","LU2476274720.SGD","LU0348735423.USD","LU0561508036.HKD","LU0348784397.USD","BK1574","IE00B5MMRT66.SGD","LU1720050803.USD","LU2399975544.HKD","LU2488822045.USD","LU0348783233.USD","LU2778985437.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667679675","title":"康方生物(09926)股價下跌5.039%，現價港幣$90.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2667679675","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667679675?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:14","pubTimestamp":1789524840,"startTime":"0","endTime":"0","summary":"[下跌股]康方生物(09926) 股价在上午10:13比前收市价下跌5.039%，现股价为港币$90.45。至目前为止，今日最高价为$94.6，而最低价为$90.45。总成交量为434.8万股，总成交金额为港币$3.991亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD260916563/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD260916563/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2399975544.HKD","LU0348825331.USD","KURE","IE00BPRC5H50.USD","LU0417516902.SGD","LU1794554557.SGD","09926","IE00B5MMRT66.SGD","LU2476274720.SGD","BK1161","LU1961090484.USD","LU2488822045.USD","LU0634319403.HKD","LU0348827113.USD","BK1574","LU0348767384.USD","LU2778985437.USD","IE00B543WZ88.USD","LU0348784397.USD","LU0417516571.SGD","LU1720050803.USD","LU2476274308.USD","LU0417516738.SGD","LU0540923850.HKD","LU0348766576.USD","LU0561508036.HKD","LU0348783233.USD","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667768406","title":"百濟神州(06160)出現大手賣出5.12萬股，成交價$214.8，涉資1.1千萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2667768406","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667768406?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 09:20","pubTimestamp":1789521600,"startTime":"0","endTime":"0","summary":"[大手成交]百济神州(06160)在上午09:20出现大手卖出，成交量为5.12万，成交价为港币$214.8，涉资1.1千万。至目前为止，股价升1.13%，今日最高价为$214.8，而最低价为$214.8，总成交量为5.12万股，总成交金额港币$1.1千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT26091646/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT26091646/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","LU1719994722.HKD","BK1583","KURE","06160","LU0588546209.SGD","LU0307460666.USD","LU0828237510.HKD","LU1303224171.USD","BK0239","LU1251922891.USD","LU1969619763.USD","BK1500","BK1588","LU0228659784.USD","LU1770034418.SGD","LU2328871848.SGD","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667389676","title":"藥明生物(02269)出現大手賣出18.3萬股，成交價$49.9，涉資913.17萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2667389676","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667389676?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 09:20","pubTimestamp":1789521600,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在上午09:20出现大手卖出，成交量为18.3万，成交价为港币$49.9，涉资913.17万。至目前为止，股价升1.382%，今日最高价为$49.9，而最低价为$49.9，总成交量为18.3万股，总成交金额港币$913.17万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT26091634/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT26091634/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0029874061.USD","LU1794554557.SGD","LU0128526141.USD","LU0359201612.USD","LU0819121731.USD","LU0039217434.USD","02269","LU1720050803.USD","LU0516423091.SGD","LU0348827113.USD","LU0307460666.USD","BK1521","LU0979878070.USD","LU0326950275.SGD","LU0823426480.USD","LU0456846285.SGD","LU0417516902.SGD","LU0708995583.HKD","LU0051755006.USD","BK1610","LU0348825331.USD","LU0823426308.USD","LU1688375341.USD","BK1589","BK1576","LU2039709279.SGD","LU3063872942.SGD","LU0043850808.USD","LU0417516738.SGD","LU0561508036.HKD","LU0320764599.SGD","LU0052750758.USD","SG9999002562.SGD","KURE","LU0572944931.SGD","LU0359202008.SGD","LU0516422952.EUR","LU0588546209.SGD","LU1242518857.USD","BK1141","LU1242518931.SGD","LU1880383366.USD","IE00B0JY6N72.USD","LU0181495838.USD","LU0516423174.USD","LU0856984785.SGD","LU0348735423.USD","LU0456827905.SGD","SG9999002463.SGD","LU0516422440.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667645058","title":"石藥集團(01093)：SYS 6010於中國獲國家藥監局納入突破性治療品種名單用於治療驅動基因陰性非鱗狀非小細胞肺癌患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2667645058","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667645058?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 18:04","pubTimestamp":1789466653,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的SYS 6010近日获中华人民共和国国家药品监督管理局纳入突破性治疗品种名单，拟定适应症为既往接受过免疫治疗及含铂化疗治疗失败的复发或转移性驱动基因阴性非鳞状非小细胞肺癌。目前，评估该产品单药用于经标准治疗失败的驱动基因阴性局部晚期或转移性非鳞状非小细胞肺癌的随机、开放、多中心III期临床试验正在开展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"石药集团(01093)：SYS 6010于中国获国家药监局纳入突破性治疗品种名单用于治疗驱动基因阴性非鳞状非小细胞肺癌患者","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0880133367.SGD","LU0501845795.SGD","LU1226287792.SGD","LU0326950275.SGD","BK1191","LU0315179316.USD","BK1521","HK0000165453.HKD","LU1226287875.USD","LU1226288253.USD","IE00BZ08YT58.USD","LU1152091168.USD","IE0008368742.USD","LU1328277881.USD","LU1993786604.SGD","LU1960683339.HKD","IE00BZ08YR35.GBP","LU1008478684.HKD","LU1152091754.HKD","LU0314109678.HKD","BK1515","IE00BZ08YS42.EUR","LU1813983027.USD","LU1807302812.USD","LU0140636845.USD","IE00B5MMRT66.SGD","KURE","IE00B031HY20.USD","LU1951186391.HKD","LU0067412154.USD","LU1226287529.USD","LU2039709279.SGD","LU0072913022.USD","IE0008369823.USD","IE00B543WZ88.USD","01093","SG9999004220.SGD","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667648612","title":"可以多活8.2個月！國產雙抗挑戰全球腫瘤「藥王」總生存期勝出","url":"https://stock-news.laohu8.com/highlight/detail?id=2667648612","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667648612?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 16:46","pubTimestamp":1789461960,"startTime":"0","endTime":"0","summary":"2026年世界肺癌大会，对于国产创新药而言，不只是“被看见”，更要回答一个硬核的问题：到底能不能让患者活得更久。继翰森制药ADC药物刷新全球小细胞肺癌二线治疗最长总生存期（OS）纪录外，另外一款国产创新药挑战全球肿瘤“药王”总生存期的数据也揭晓了。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609153874734252.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609153874734252.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1066053197.SGD","LU2360032135.SGD","LU0348784397.USD","SG9999014542.SGD","BK4588","IE0009355771.USD","SG9999015341.SGD","LU0942090050.USD","LU0823416689.USD","MRK","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU0965508806.USD","LU2461242641.AUD","LU0348783233.USD","LU1989772923.USD","LU2491049909.HKD","LU0980610538.SGD","LU2125909247.SGD","LU0266013472.USD","SG9999014575.USD","LU2324357040.USD","LU0057025933.USD","LU1571399168.USD","LU1069347547.HKD","LU0511384066.AUD","IE00BJJMRZ35.SGD","LU2491050071.SGD","LU1917777945.USD","PPH","BK1574","SG9999001440.SGD","LU2491050154.USD","GDOC","LU1066051498.USD","SG9999013999.USD","LU1093756168.USD","LU1116320901.HKD","LU1037948541.HKD","IE00BBT3K403.USD","HRTS","LU0868494617.USD","IE00B1BXHZ80.USD","IE00BN8TJ469.HKD","LU0130102774.USD","LU1934455194.USD","TRUH","LU1162221912.USD","LU2778985437.USD","SG9999002232.USD","SG9999002224.SGD","BK4516","BK4007","LU0348766576.USD","LU1066051225.USD","LU2476274720.SGD","LU0859254822.USD","FTXH","LU0689626769.HKD","LU0868494708.USD","SG9999014559.SGD","IE00BSNM7G36.USD","LU0648001328.SGD","LU2468319806.SGD","LU0348825331.USD","LU1941712264.USD","LU0985320562.USD","SG9999001176.SGD","LU0070302665.USD","IE00B543WZ88.USD","LU1035773651.USD","LU0477156953.USD","LU0289961442.SGD","XLV","LU0122379950.USD","LU0203347892.USD","LU2433249047.HKD","BK4559","SG9999015358.SGD","LU1929549753.HKD","IE00B2B36J28.USD","BK4550","KURE","LU1923622614.USD","LU1061106388.HKD","LU2476274308.USD","LU1934455863.HKD","LU0130517989.USD","LU1585245621.USD","LU2106854487.HKD","LU1066051811.HKD","LU0006306889.USD","LU1032466523.USD","LU0069063385.USD","LU0634319403.HKD","LU0058720904.USD","LU2125909593.SGD","LU2361045086.USD","LU2023250843.SGD","LU1989771016.USD","LU1934455277.USD","LU0106261372.USD","LU1699723380.USD","LU1941712348.USD","LU0432979614.USD","LU0861579265.USD","IE000M9KFDE8.USD","LU0417516902.SGD","IHE","LU0965509010.AUD","LU2399975544.HKD","LU1116320737.USD","LU2488822045.USD","IE00BLSP4239.USD","BK4533","LU0211331839.USD","LU0348767384.USD","LU0320765646.SGD","LU1037948897.HKD","BMED","IXJ","SG9999014567.USD","SG9999001176.USD","LU0208291251.USD","09926","LU0124676726.USD","SGXZ57979304.SGD","LU0234572021.USD","LU2361044949.HKD","RXL","LU1720050803.USD","IE0002141913.USD","LU1291159041.SGD","LU0561508036.HKD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU1794554557.SGD","LU1057294990.SGD","LU0203345920.USD","LU0348827113.USD","LU1989772840.SGD","LU0417516571.SGD","PAWZ","BK1161","LU0965509283.SGD","LU2125154935.USD","LU1430594728.SGD","LU0289739343.SGD","IYH","LU1961090484.USD","LU2089984988.USD","LU2112291526.USD","VHT","LU0540923850.HKD","LU2125154778.USD","BK4585","LU0472753341.HKD","LU1093756325.SGD","JDOC","LU1201861249.SGD","FHLC","BK4534","LU0320765489.SGD","LU0265550359.USD","LU0417516738.SGD","LU0265550946.USD","IE00B5MMRT66.SGD","LU0238689110.USD","IE00B4R5TH58.HKD","IE00BPRC5H50.USD","LU2023250504.SGD","LU0965509101.SGD","LU0098860793.USD","LU1983299246.USD","LU2361044865.SGD","LU0348735423.USD","IE00BLSP4452.SGD","LU2357627491.SGD","LU1974910355.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691412","title":"智通港股早知道 | 國產創新藥WCLC數據密集兑現 投行看好中國CRO/CDMO復甦明確","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691412","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691412?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 07:29","pubTimestamp":1789428595,"startTime":"0","endTime":"0","summary":"WCLC临床数据密集兑现，国内外投行相继看好中国CRO/CDMO复苏明确9月12日至15日，2026年世界肺癌大会在韩国首尔举行，多项国产创新药临床数据集中亮相，中国新药入选口头报告19项、小型口头报告45项，双双刷新历史纪录，肺癌领域ADC与双抗数据成为焦点。经初步测算，本次交易完成后，一汽股份将成为公司第二大和具有战略影响力的股东;本次交易预计构成重大资产重组及关联交易，不构成公司实际控制人变更，不构成重组上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B543WZ88.USD","IE0008369823.USD","KCAI","06871","BK1574","LU1226288170.HKD","LU1993786604.SGD","BK4585","06978","BK1147","BK1161","LU1226287875.USD","IE00BZ08YT58.USD","LU1008478684.HKD","LNGR","LU0315179316.USD","BK1144","LU0501845795.SGD","VXUS","01093","LU1951186391.HKD","LU0314109678.HKD","LU1960683339.HKD","BK1183","LU1152091754.HKD","LU1226287529.USD","LU0326950275.SGD","02889","LU2039709279.SGD","MEDX","159992","LU1813983027.USD","IE0008368742.USD","CDMO","BK1539","BK4588","IE00B5MMRT66.SGD","KURE","BK1191","01911","02238","BK1119","BK4139","HK0000165453.HKD","LU0140636845.USD","LU1226287792.SGD","SG9999004220.SGD","LU1328277881.USD","BK1521","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}